|
|
Volumn 12, Issue 1, 2011, Pages 16-17
|
|
NICE guidance on trastuzumab for the treatment of HER2-positive metastatic gastric cancer.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ERBB2 PROTEIN, HUMAN;
MONOCLONAL ANTIBODY;
TRASTUZUMAB;
CHEMISTRY;
DRUG ANTAGONISM;
HEALTH CARE COST;
HUMAN;
NOTE;
PRACTICE GUIDELINE;
QUALITY ADJUSTED LIFE YEAR;
STOMACH TUMOR;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
HEALTH CARE COSTS;
HUMANS;
PRACTICE GUIDELINES AS TOPIC;
QUALITY-ADJUSTED LIFE YEARS;
RECEPTOR, ERBB-2;
STOMACH NEOPLASMS;
MLCS;
MLOWN;
|
|
EID: 79952216192
PISSN: None
EISSN: 14745488
Source Type: Journal
DOI: 10.1016/s1470-2045(10)70276-x Document Type: Note |
|
Times cited : (13)
|
|
References (0)
|
